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Abstract
Objective. Evaluation of the presence of symptoms of anxiety and depression in women treated for breast cancer who 
underwent surgical procedure using one of two alternative methods, either radical mastectomy or breast conserving 
treatment (BCT).  
Methods. A questionnaire survey involved 85 patients treated in a conservative way and 94 patients after breast amputation. 
Hospital Anxiety and Depression Scale (HADS), Beck Depression Inventory (BDI) and depression degree evaluation 
questionnaire were used in the study. The patients’ responses were statistically analyzed.  
Results. Based on the HADS questionnaire, the total anxiety level in the group of women treated with BCT was 6.96 points, 
while in the group of patients who had undergone mastectomy the value was 7.8 points. The observed results were 
statistically significant.  
In the case of depression, the following values were found: patients after amputation had 8.04 scale value points, and those 
after BCT had 6.8 scale value points. The observed differences were statistically significant. Negative correlation was found 
between the level of anxiety and depression. The total level of depression evaluated using the Beck scale was 16.3 points 
in the BCT group, which means that they suffered from mild depression, while in the mastectomy group the level was 19.6 
points, which corresponds to moderate depression.  
Conclusions. The level of anxiety and depression among women with breast cancer was influenced by the type of the 
applied surgical procedure and adjuvant chemotherapy.  
Demographic variables did not influence the level of anxiety and depression.
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INTRODUCTION
In Poland, breast cancer is the most prevalent malignant 
neoplasm in women, constituting about 22.4% of all cases 
of malignancy [1].
Breast cancer treatment is a combined therapy, with the 
sequence and time of therapeutic activities established 
according to certain universal standards adopted and applied 
in Poland and worldwide. The basic rule for therapeutic 
process in the early stages of neoplastic progression is 
primary application of surgical procedure complemented 
with postsurgical radiotherapy (RTH), depending on the 
indications [2].
The main purpose of surgical treatment is ensuring 
oncological radicality, as well as obtaining data concerning 
pathological advancement of the neoplasm. Two types of 
surgical procedures are used in course of breast cancer 
treatment: breast conserving treatment (BCT) and breast 
amputation (mastectomy) [3].
The methods of breast cancer treatment have a well 
established therapeutic value but surgical treatment, 
chemotherapy, radiotherapy and hormonal therapy are 
associated with the occurrence of adverse effects. Clinical 
symptoms of the side-effects may occur as transient, non-
specific changes without any influence on the comfort of 
patient’s life, or they can form characteristic syndromes 
significantly affecting the patient’s daily activity and 
decreasing the quality of patient’s life. Coping with neoplastic 
disease is often a prolonged process adversely affecting the 
patient’s previous lifestyle and quality of life.
It is commonly believed that a neoplastic disease seals the 
patient’s fate. Such a psychological burden results from the 
fact of the life-threatening situtation, occurrence of pain, 
treatment, dependence on medications, being dependent on 
others, necessity of repeated hospitalizations, loss of control of 
one’s life, and uncertainty concerning the nearest future. The 
patient is powerless and does not have any influence on the 
course of the disease. This lack of personal control may deepen 
the passive attitude towards the whole process of treatment [4].
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Patients diagnosed with breast cancer encounter many 
specific problems at all stages of diagnostics, therapy, 
rehabilitation, remission or progression. They concern their 
health status, as well as immediate and distant adverse effects 
of the applied oncological treatment.
Psychological problems, such as a persisting sense of 
threat to the patient’s life with resulting anxiety, depression, 
cancerophobia, lack of self-acceptance, and a sense of threat 
to existential and spiritual needs, are as important as physical 
symptoms [5]. Domination and intensity of some of them, 
to a large degree, depend on the course of the disease, its 
progression and patient’s individual features [6].
Neoplastic diseases are characterized by their dynamic 
course of progression which requires the patients to have the 
ability to deal with constantly changing situation. How the 
patients deal with the emotions associated with the disease 
depends, among others, on the information they have on 
the disease, its treatment and other patients’ reaction to 
the disease [7]. Lack of reliable information concerning the 
disease or incorrect information based on stereotypes form 
inadequate emotional responses towards the disease and 
its treatment. Precise monitoring of the negative emotions, 
especially anxiety and depression, is an important element 
of healthcare because their intensification may interfere with 
appropriate course and efficiency of treatment [8].
OBJECTIVES
The purpose of the study was evaluation of the intensity 
of anxiety and depression in women treated for breast 
cancer who had undergone either of the two methods of 
surgical procedure: radical mastectomy or breast conserving 
treatment (BCT), followed by systemic adjuvant treatment. 
The following research problems were posed:
1. Did the application of surgical procedure influence the level 
of anxiety and depression in women with breast cancer?
2. What was the influence of social and demographic factors 
on the intensity of anxiety and depression?
3. Did the application of adjuvant chemotherapy following 
surgical procedure influence the intensity of anxiety and 
depression?
The following research activities were conducted to fulfill 
the purpose of the study:
 – analysis of data obtained using The Hospital Anxiety and 
Depression Scale (HADS);
 – analysis of data obtained using the Beck Depression 
Inventory (BDI);
 – analysis of data obtained using our own questionnaire 
attached to the main study;
 – in-depth analysis of the elements distinguishing the two 
study groups concerning demographic data and the applied 
surgical procedure.
MATERIALS AND METHOD
The questionnaire survey involved 85 patients treated 
by breast conserving treatment and 94 patients who had 
undergone mastectomy. All patients were treated in the 
Lublin Region Oncology Centre (COZL) and Clinic for 
Surgical Oncology at the Medical University in Lublin in the 
years 2005–2007. The study was performed after obtaining 
a positive opinion from the Bioethical Committee at the 
Medical University in Lublin.
Study group characteristics. Mean age within the study 
group was ±53 years. The youngest patient was aged 32 and 
the oldest 73. In both study subgroups, 116 patients lived in 
cities, 19 lived in small towns and 44 in rural areas. Altogether, 
135 patients came from cities and towns. The largest number 
of patients, namely 85, had secondary education, 53 higher 
education and 41 had vocational education. The majority of 
women were married – 141 (78.8%). All study subjects (100%) 
had undergone surgical procedures (BCT, mastectomy) and 
received one course of adjuvant chemotherapy.
Hospital Anxiety and Depression Scale modified by 
Majkowicz, de Walden-Gałuszko, Chojnacka-Szawłowska 
and Magiera was used in the study [9]. HADS is used for 
screening for anxiety and depression in patients undergoing 
oncological treatment [10]. The responses are evaluated using 
a four-point Likert-type scale – from 0–3. In both anxiety 
and depression subscales the results were summed-up. Values 
from 0–7 indicate normal levels, 8–10 are border values (slight 
anxiety disorders), and values from 11–21 are considered to 
be pathological (anxiety disorder) [11].
The Beck Self-evaluation Scale is a well known questionnaire 
used for evaluation of the presence and intensity of depression 
[12].(The scale consists of 21 descriptions of groups of 
symptoms, and the patient has to choose the one that 
best describes the state in the indicated time period. The 
following criteria were adopted for measuring the intensity 
of depression: 0–4 no depression; 5–7 mild depression; 8–15 
moderate depression; over 16 points severe depression. The 
level of depression has been calculated according to various 
standards (e.g. German standard, American standard). The 
Beck Self-evaluation Scale is not sufficient for diagnosing or 
excluding depressive disorders; the test may only be helpful 
in diagnostics and used for monitoring the efficiency of 
the applied treatment. The questionnaire was filled- in by 
the patients after the first course of adjuvant chemotherapy 
following surgical treatment.
The description of the study group with respect to continuous 
variables (e.g. age) was conducted using the Descriptive 
Statistics module of Statistica StatSoft v. 7.1. software. The 
characterization of the study group was performed using 
basic demographic data. Depending on the distribution of 
the analyzed elements, they were described with either a 
median or average value, as well as a range of percentiles and 
standard deviation. In the case of differences between the two 
subgroups, Nonparametric Statistics module tests were used, 
U Mann-Whitney and Kolmogorov-Smirnov, respectively. 
In order to discover the differences in the preferences of the 
two subgroups McNemara c2 test was used. The calculations 
were performed for the confidence interval CI = 95%. Thus, 
the differences with statistical significance were those for 
which the p value met the condition of p < 0.05.
Study results description. Evaluation of degree of anxiety 
and depression.
Analysis of data obtained from the HADS questionnaire 
showed that the perceived level of anxiety and depression was 
higher among the patients who had undergone mastectomy, 
compared to the patients after BCT (Tab. 1).
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Table 1. Results of studies using HADS questionnaire in the group of 












1 anxiety 65.7 54.6 **
2 depression 26.7 15.4 **
3 anxiety 34.3 26.2 **
4 depression 30.0 19.3 **
5 anxiety 41.3 36.5
6 depression 36.6 28.0 **
7 anxiety 50.3 39.5 *
8 depression 45.0 34.7
9 anxiety 29.0 25.6
10 depression 43.7 32.8 **
11 anxiety 18.0  9.0 **
12 depression 19.7 15.4 *
13 anxiety 30.0 21.7 **
14 depression 70.3 62.4
Significance of differences in the distribution of responses to questions according to HADS scale.
* – p<0.05; ** – p <0.01
The study subjects with high anxiety values were also 
characterized with higher intensity of depression. Analysis 
of the level of anxiety and depression in the subgroups of 
patients after either mastectomy or BCT showed higher level 
of anxiety and depression within all the criteria evaluated 
by the questionnaire. In the case of 10 out of 14 elementary 
criteria, the differences were statistically significant (Tab. 1).
Analysis of data presented in Figure 2 shows that the total 
level of anxiety in patients who had undergone mastectomy 
was 7.8 points, while patients after BCT the value was 6.96 
points. In case of depression, the following values were 
observed: 8.04 in patients after mastectomy and 6.8 points 
in patients after BCT. U Mann-Whitney test confirmed that 
the noted differences were statistically significant, p< 0.01.
The survey conducted with the HADS questionnaire 
showed that 38.4% of patients after mastectomy and 30.4% 
patients after BCT suffered from anxiety. Symptoms of 
depression occurred in 38.9% of patients after mastectomy 
and 29.7% in the case of patients after BCT. Application of 
systemic adjuvant treatment following the above-mentioned 
surgical procedures contributed to increased prevalence 
of anxiety and depression, reaching 64% of women after 
mastectomy and 52.4% of women after BCT.
A positive correlation was found between high level of 
anxiety and depression. It was also found that anxiety and 
depression depended on such factors as: having children, 
having a partner and the level of education. It was proved 
that anxiety and depression are intrinsically connected with 
breast cancer.
No statistically significant correlation was found between 
the intensity of depression and the level of anxiety, and the 
patients’ age and health status (p>0.05). However, an obvious 
tendency was observed in the study group, older patients 
were more prone to depression.
No differences in the intensity of depression were observed 
between patients living in urban and rural areas. At the same 
time, it was found that study participants residing in rural 
areas were more likely to react to breast cancer diagnosis with 
stronger anxiety. The level of education did not influence the 
level of anxiety and depression in the study group (p>0.05). 
Single women were more prone to depression compared to 
those who were married (p>0.05).
Figure 3. Comparison of the level of depression and anxiety measured using Beck 
scale, broken down into respective questions in the subgroups of patients who had 
undergone either of the two surgical procedures, mastectomy or BCT followed by 
systemic adjuvant treatment.
The significance of differences in the distribution of responses to questions 
* – p<0.05; ** – p <0.01
Figure 1. Comparison of perceived level of anxiety and depression based on HADS 
questionnaire, broken down into respective questions in the groups of patients 
who had undergone surgical procedures, either mastectomy or BCT, followed by 
systemic adjuvant treatment
Figure 2. Comparison of perceived anxiety and depression on the basis of HADS 
questionnaire in the groups of patients who had undergone surgical procedures: 
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DISCUSSION
Despite great progress in the sphere of treatment methods, 
application of new radiotherapy techniques and introduction 
of new cytostatic medications, the prognosis for women 
diagnosed with breast cancer is not favourable. Thanks 
to modern treatment methods, many patients may reach 
long-term remission lasting months or even years, but 
there is also a group of patients who, due to the degree of 
disease progression, may only obtain periodical life quality 
improvement, symptoms relief and possibly life period 
extension [13].
The occurrence of psychological problems in women 
diagnosed with breast cancer is quite common. Among the 
unfavourable psychological consequences of breast cancer, 
the most important are fear, anger and sadness, but first and 
foremost anxiety and depression [14]. Precise assessment of 
the extent of the problem is difficult – it is estimated that it 
concerns 10–25% of patients with neoplastic disease [15]. 
Studies conducted among patients with breast cancer treated 
with adjuvant chemotherapy demonstrated the presence of 
clinical depression in about 37% [16].
The authors of the presented study analyzed whether social 
and demographic factors such as: age, education, marital status 
and place of residence influence evaluation of the intensity 
of anxiety and depression in women who had undergone 
either of the two methods of surgical procedure: mastectomy 
or BCT, followed by adjuvant chemotherapy. Education did 
not influence the level of anxiety and depression within the 
study group (p>0.05). In a study conducted by Khademi 
et al., a lower level of education was correlated with a higher 
frequency of symptoms of depression [17]. In own studies, 
statistically significant correlations were found between 
the intensity of depression and the patients’ marital status. 
Single women were characterized with a higher intensity of 
depression, compared to those who were married (p>0.05). 
Similar conclusions were drawn by Nowicki et  al. [18]. 
Depression occurred more frequently in single and childless 
women, the intensity of anxiety was also higher. Moreover, 
Karakoyun-Celik et al. [14] demonstrated that the absence 
of a spouse during follow-up hospital examinations had a 
negative influence on the patients psychological condition, 
leading to higher intensity of anxiety and depression. It 
seems that the level of anxiety and depression in women 
is affected not only by their marital status, but also by the 
quality of their relationship and communication between 
partners [19]. Higher intensity of depression leads to family 
tensions, increased emotional excitability and a pessimistic 
vision of the future. On the other hand, disordered family 
relations and lack of support from their families are related to 
the states of depression and anxiety experienced by patients 
with breast cancer [20].
The results obtained in the presented study show that 
residents of rural areas experience more intense anxiety 
than residents of urban areas, which may be caused by 
less developed adaptational ability to cope with treatment 
conditions. Burris JL and Andrykowski M. [21] pointed out 
the disproportions in the psychological health of oncological 
patients from rural and urban areas. The differences are 
expressed by higher frequency of anxiety and occurrence of 
symptoms of depression symptoms, as well as more serious 
emotional problems experienced by residents of rural areas. 
The authors concluded that this population requires special 
intervention and better access to mental health specialists. 
Similar conclusions were drawn by Weaver et al. [22] after 
conducting a questionnaire survey – patients diagnosed 
with neoplastic disease who resided in rural areas had worse 
outcomes in all aspects of their health, including more intense 
psychological distress in this group of patients.
Most studies and a systematic review of the literature 
indicate that patients who had undergone BCT are 
characterized with a lower level of anxiety and depression 
than patients after mastectomy [23]. In own studies, it was 
confirmed that a higher level of anxiety and depression 
occurred in patients who had undergone mastectomy. After 
breast amputation, apart from physical changes, the patients 
also experienced unfavourable psychological changes. They 
were characterized by the so-called ‘half woman’ complex 
[24], characterized by decreased self-esteem, lack of own 
body acceptance, anxiety about the loss of femininity, sexual 
attractiveness and relationship with the partner.
Studies of the level of anxiety and depression are measurable 
results of the conducted treatment and broadly defined 
patient nursing. A positive correlation was found between 
high level of anxiety and depression. Similar results were 
obtained by Juszczyński [25]. The helplessness-hopelessness 
syndrome and focus on anxiety are positively correlated with 
anxiety and depression.
Own studies confirmed that the level of anxiety and 
depression accompanying women after surgical procedure 
was not only a feature of their personality, but very often an 
unpleasant psychological condition connected with everyday 
struggle with the disease.
CONCLUSIONS
4. The symptoms of anxiety and depression were dominant 
and more intense among women who had undergone 
mastectomy.
5. The study results revealed a correlation between the 
intensity of anxiety and depression in patients treated for 
breast cancer and socio-economic factors such as having 
children, marital status and the level of education.
6. Symptoms of depression occurred in 29.7% patients after 
BCT and 38.9% after mastectomy, while the prevalence of 
anxiety was 30.4% of women after BCT and 38.4% after 
mastectomy.
7. The obtained results indicate the high complexity of mutual 
relations between the disease itself, socio-economic factors, 
and the intensity of anxiety and depression.
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